Abstract
Background Intensive and high-dose upper extremity training, concentrating on movement quality in the early phase after a stroke, can enhance motor recovery compared to standard care. Unfortunately, such programs do not exist due to limited resources, patient compliance, and administrative challenges.
Objective To examine the feasibility and potential efficacy, and to evaluate the resources of an intensive technology-based upper extremity training emphasizing movement quality during inpatient stroke rehabilitation.
Methods Twelve subjects with hemiparesis underwent 40 60-minute sessions over a 4-week period, in addition to standard care. The training included two game-based virtual reality platforms to practice proximal (tech 1) and distal (tech 2) movements with daily assessments.
Results Eight subjects completed the entire protocol, three subjects completed 34–38 sessions, and one subject completed only 27 sessions. The mean time on each task was 35±4 (tech 1) and 37±2 (tech 2) minutes per hour. The intervention was perceived as motivating and enjoyable [Intrinsic Motivation Inventory (IMI) enjoyment and interest= 6.49±0.66 out of 7] and was not associated with pain [Visual Analogue Scale (VAS) mean= 2.00±2.32]. Subjects showed large improvements in all impairment measurements (mean FMA delta= 16.5 points and ARAT delta= 22.9 points).
Conclusions The results support the feasibility of a high-dose high-intensity supplementary training protocol during sub-acute hospitalization and provide suggestive evidence of its efficacy.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04737395
Funding Statement
This work was supported by the Israeli Science Foundation grant 1244/22 to LS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Regional Ethical Review Board at Sheba Medical Center, Israel (Approval Number 6218-19-SMC), and registered with ClinicalTrials.gov (NCT04737395) prior to the start of enrollment. All subjects signed a consent form before performing the experiment.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Authors email addresses: Reut Binyamin-Netser - reutbi5766{at}gmail.com, Shirley Handelzalts - handelza{at}bgu.ac.il, Noy Goldhamer - noygoldhamer{at}gmail.com, Inbar Avni - inbavn{at}gmail.com, Adi Yeshurun Tayer - adiyes{at}gmail.com, Yogev Koren - yogevk{at}post.bgu.ac.il, Ofri Bibas Levy - ofri.bibas{at}gmail.com, Shilo Kramer - shilok{at}adi-il.org, Simona Bar Haim - Adi-star{at}013.net, Lior Shmuelof - shmuelof{at}bgu.ac.il
Data Availability
All data produced in the present study are available upon reasonable request to the authors
